Biolinerx (BLRX) Posts Q1 Loss of 1c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Biolinerx (BLRX) Posts Q1 Loss of 1c/Share

Aegis Keeps BioLineRx (BLRX) at 'Buy'; Plenty of Catalysts Happening Over Next 12 Months

May 21, 2014 9:26 AM EDT

Aegis Capital maintained BioLineRx, Ltd. (Nasdaq: BLRX) at Buy with a $7 price target following Q1 results. After markets closed Tuesday, BioLineRx reported Q1 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11).

Analyst Ram Selvaraju said, The firm ended the quarter with $37.5mm in cash, following a recent financing round that raised $24.1mm in net proceeds from the sale of roughly 9.7mm American... More